{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:44:07Z","timestamp":1774615447755,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12022-021-09681-2","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:02:42Z","timestamp":1621591362000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-2402","authenticated-orcid":false,"given":"Hussein","family":"Nassereddine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Chicaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khedidja","family":"Rebah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Th\u00e9ou-Anton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sautet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Dermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Couvelard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"18","key":"9681_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008 Jun 20;26(18):3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol."},{"key":"9681_CR2","doi-asserted-by":"publisher","unstructured":"Delle Fave G, O\u2019\u2019Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, et al. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology. 2016;103(2):119\u201324. https:\/\/doi.org\/10.1159\/000443168","DOI":"10.1159\/000443168"},{"issue":"4","key":"9681_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","volume":"104","author":"G Rindi","year":"1993","unstructured":"Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993 Apr;104(4):994\u20131006.","journal-title":"Gastroenterology."},{"key":"9681_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.04.005","volume":"29","author":"JY Kim","year":"2017","unstructured":"Kim JY, Hong S-M, Ro JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017 Aug;29:11\u20136. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.04.005","journal-title":"Ann Diagn Pathol."},{"issue":"46","key":"9681_CR5","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","volume":"19","author":"S Grozinsky-Glasberg","year":"2013","unstructured":"Grozinsky-Glasberg S. Metastatic type 1 gastric carcinoid: A real threat or just a myth? World J Gastroenterol. 2013;19(46):8687. https:\/\/doi.org\/10.3748\/wjg.v19.i46.8687","journal-title":"World J Gastroenterol."},{"issue":"2","key":"9681_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/EJE-12-0836","volume":"168","author":"D Thomas","year":"2013","unstructured":"Thomas D, Tsolakis AV, Grozinsky-Glasberg S, Fraenkel M, Alexandraki K, Sougioultzis S, et al. Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study. Eur J Endocrinol. 2013 Feb;168(2):185\u201393. https:\/\/doi.org\/10.1530\/EJE-12-0836","journal-title":"Eur J Endocrinol."},{"key":"9681_CR7","unstructured":"La Rosa S, Rindi G, Solcia E, Tang LH (2019). Gastric neuroendocrine neoplasms. In WHO classification of tumours editorial board (Eds.). Digestive system tumours (5th edition, pp. 104\u2013110). Lyon. ISBN 978\u201392\u2013832\u20134499\u20138"},{"issue":"3","key":"9681_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ecl.2018.04.008","volume":"47","author":"F Inzani","year":"2018","unstructured":"Inzani F, Petrone G, Rindi G. The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. Endocrinol Metab Clin North Am. 2018 Sep;47(3):463\u201370. https:\/\/doi.org\/10.1016\/j.ecl.2018.04.008","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"5","key":"9681_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MEG.0b013e328350fae8","volume":"24","author":"MP Spampatti","year":"2012","unstructured":"Spampatti MP, Massironi S, Rossi RE, Conte D, Sciola V, Ciafardini C, et al. Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature. Eur J Gastroenterol Hepatol. 2012 May;24(5):589\u201393. https:\/\/doi.org\/10.1097\/MEG.0b013e328350fae8","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"2","key":"9681_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000489902","volume":"107","author":"A Vanoli","year":"2018","unstructured":"Vanoli A, La\u00a0Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, et al. Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: analysis of 200 cases with extended follow-up. Neuroendocrinology. 2018;107(2):114\u201326. https:\/\/doi.org\/10.1159\/000489902","journal-title":"Neuroendocrinology."},{"issue":"11","key":"9681_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jclinpath-2014-202515","volume":"67","author":"S La Rosa","year":"2014","unstructured":"La Rosa S, Vanoli A. Gastric neuroendocrine neoplasms and related precursor lesions. J Clin Pathol. 2014 Nov;67(11):938\u201348. https:\/\/doi.org\/10.1136\/jclinpath-2014-202515","journal-title":"J Clin Pathol."},{"key":"9681_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/287825","volume":"2012","author":"GC Nikou","year":"2012","unstructured":"Nikou GC, Angelopoulos TP. Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract. 2012;2012:1\u20138. https:\/\/doi.org\/10.1155\/2012\/287825","journal-title":"Gastroenterol Res Pract."},{"issue":"10","key":"9681_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.dld.2019.04.016","volume":"51","author":"F Panzuto","year":"2019","unstructured":"Panzuto F, Campana D, Massironi S, Faggiano A, Rinzivillo M, Lamberti G, et al. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study. Dig Liver Dis. 2019 Oct;51(10):1456\u201360. https:\/\/doi.org\/10.1016\/j.dld.2019.04.016","journal-title":"Dig Liver Dis."},{"issue":"4","key":"9681_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.9738\/CC134.1","volume":"97","author":"S Endo","year":"2012","unstructured":"Endo S, Dousei T, Yoshikawa Y, Hatanaka N, Taniyama K, Yamauchi A, et al. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification. Int Surg. 2012 Dec;97(4):335\u20139. https:\/\/doi.org\/10.9738\/CC134.1","journal-title":"Int Surg."},{"issue":"11","key":"9681_CR15","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.10901","volume":"105","author":"B-H Min","year":"2018","unstructured":"Min B-H, Hong M, Lee JH, Rhee P-L, Sohn TS, Kim S, et al. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours: Low-grade type 3 gastric neuroendocrine tumours. Br J Surg. 2018 Oct;105(11):1480\u20136. https:\/\/doi.org\/10.1002\/bjs.10901","journal-title":"Br J Surg."},{"issue":"3","key":"9681_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12022-016-9443-6","volume":"27","author":"HE Lee","year":"2016","unstructured":"Lee HE, Mounajjed T, Erickson LA, Wu T-T. Sporadic gastric well-differentiated neuroendocrine tumors have a higher ki-67 proliferative index. Endocr Pathol. 2016 Sep;27(3):259\u201367. https:\/\/doi.org\/10.1007\/s12022-016-9443-6","journal-title":"Endocr Pathol."},{"issue":"10","key":"9681_CR17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.humpath.2011.01.018","volume":"42","author":"S La Rosa","year":"2011","unstructured":"La Rosa S, Inzani F, Vanoli A, Klersy C, Dainese L, Rindi G, et al. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol. 2011 Oct;42(10):1373\u201384. https:\/\/doi.org\/10.1016\/j.humpath.2011.01.018","journal-title":"Hum Pathol."},{"issue":"10","key":"9681_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1634\/theoncologist.2015-0476","volume":"21","author":"R Coriat","year":"2016","unstructured":"Coriat R, Walter T, Terris B, Couvelard A, Ruszniewski P. Gastroenteropancreatic well-differentiated grade 3 neuroendocrine tumors: review and position statement. The Oncologist. 2016 Oct;21(10):1191\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2015-0476","journal-title":"The Oncologist."},{"issue":"6021","key":"9681_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011 Mar 4;331(6021):1199\u2013203. https:\/\/doi.org\/10.1126\/science.1200609","journal-title":"Science."},{"issue":"3","key":"9681_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ando.2019.04.010","volume":"80","author":"A Scarpa","year":"2019","unstructured":"Scarpa A. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. Ann Endocrinol. 2019 Jun;80(3):153\u20138. https:\/\/doi.org\/10.1016\/j.ando.2019.04.010","journal-title":"Ann Endocrinol."},{"issue":"3","key":"9681_CR21","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1530\/JOE-17-0560","volume":"236","author":"A Mafficini","year":"2018","unstructured":"Mafficini A, Scarpa A. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium. J Endocrinol. 2018 Mar;236(3):R161\u20137. https:\/\/doi.org\/10.1530\/JOE-17-0560","journal-title":"J Endocrinol."},{"key":"9681_CR22","doi-asserted-by":"publisher","unstructured":"Lee J, Sung CO, Lee EJ, Do I-G, Kim H-C, Yoon SH, et al. Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene. Agoulnik I, editor. PLoS ONE. 2012 Apr 2;7(4):e34456. https:\/\/doi.org\/10.1371\/journal.pone.0034456","DOI":"10.1371\/journal.pone.0034456"},{"key":"9681_CR23","doi-asserted-by":"publisher","unstructured":"Australian Pancreatic Cancer Genome Initiative, Scarpa A, Chang DK, Nones K, Corbo V, Patch A-M, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017 Mar;543(7643):65\u201371. https:\/\/doi.org\/10.1038\/nature21063","DOI":"10.1038\/nature21063"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-021-09681-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T19:15:47Z","timestamp":1637608547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-021-09681-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9681"],"URL":"https:\/\/doi.org\/10.1007\/s12022-021-09681-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"11 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}